Patents by Inventor Robert Trygve Good

Robert Trygve Good has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic compositions for treating infection by Lawsonia spp.
    Patent number: 6846487
    Abstract: The present invention relates generally to therapeutic compositions for the treatment and/or prophylaxis of intestinal disease conditions in animals and birds caused or exacerbated by Lawsonia intracellularis or similar or otherwise related microorganism. In particular, the present invention provides a novel gene derived from Lawsonia intracellularis, which encodes an immunogenic polypeptide that is particularly useful as an antigen in a vaccine preparation for conferring humoral immunity against Lawsonia intracellularis and related pathogens in animal hosts, wherein said polypeptide is selected from the group consisting of flhB, fliR, ntrC, glnH, motA, motB, tlyC, ytfM, and ytfN polypeptides, or a homologue, analogue or derivative of any one or more of said polypeptides.
    Type: Grant
    Filed: November 9, 2001
    Date of Patent: January 25, 2005
    Assignees: Pfizer Inc., Agriculture Victoria Services Pty Ltd., Austrailian Pork Limited
    Inventors: Everett Lee Rosey, Kendall Wayne King, Robert Trygve Good, Richard Anthony Strugnell
  • Novel therapeutic compositions for treating infection by Lawsonia spp.
    Publication number: 20030103999
    Abstract: The present invention relates generally to therapeutic compositions for the treatment and/or prophylaxis of intestinal disease conditions in animals and birds caused or exacerbated by Lawsonia intracellularis or similar or otherwise related microorganism. In particular, the present invention provides a novel gene derived from Lawsonia intracellularis, which encodes an immunogenic polypeptide that is particularly useful as an antigen in a vaccine preparation for conferring humoral immunity against Lawsonia intracellularis and related pathogens in animal hosts, wherein said polypeptide is selected from the group consisting of flhB, fliR, ntrC, glnH, motA, motB, tlyC, ytfM, and ytfN polypeptides, or a homologue, analogue or derivative of any one or more of said polypeptides.
    Type: Application
    Filed: November 9, 2001
    Publication date: June 5, 2003
    Inventors: Everett Lee Rosey, Kendall Wayne King, Robert Trygve Good, Richard Anthony Strugnell